A carregar...

A mass spectrometry-based method to quantify in parallel Tau and amyloid β 1–42 in CSF for the diagnostic of Alzheimer’s Disease

Alzheimer’s disease (AD), the most common form of dementia, afflicts about 50 million people worldwide. Currently, AD diagnosis is primarily based on psychological evaluation and can only be confirmed post-mortem. Reliable and objective biomarkers for prognosis and diagnosis have been sought for sev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Proteome Res
Main Authors: Pottiez, Gwënaël, Yang, Li, Stewart, Tessandra, Song, Ning, Aro, Patrick, Galasko, Doug, Quinn, Joseph, Peskind, Elaine, Shi, Min, Zhang, Jing
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679294/
https://ncbi.nlm.nih.gov/pubmed/28112948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jproteome.6b00829
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!